A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Clinical trial NCT01461980 · COMPLETED

Trial details

NCT number: NCT01461980
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Vaccines Meningococcal Vaccines

Start date: 2011-09-28
Primary completion: 2014-05-08
Enrollment: 2648

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.